1. Home
  2. CBSH vs CYTK Comparison

CBSH vs CYTK Comparison

Compare CBSH & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commerce Bancshares Inc.

CBSH

Commerce Bancshares Inc.

HOLD

Current Price

$50.52

Market Cap

8.1B

Sector

Finance

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$64.98

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBSH
CYTK
Founded
1865
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.1B
7.6B
IPO Year
2008
2004

Fundamental Metrics

Financial Performance
Metric
CBSH
CYTK
Price
$50.52
$64.98
Analyst Decision
Hold
Strong Buy
Analyst Count
8
18
Target Price
$59.22
$88.94
AVG Volume (30 Days)
985.1K
1.8M
Earning Date
04-21-2026
05-05-2026
Dividend Yield
2.05%
N/A
EPS Growth
4.39
N/A
EPS
4.04
N/A
Revenue
N/A
$13,368,000.00
Revenue This Year
$17.20
$6.88
Revenue Next Year
$3.44
$308.26
P/E Ratio
$12.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$46.99
$29.31
52 Week High
$66.31
$70.98

Technical Indicators

Market Signals
Indicator
CBSH
CYTK
Relative Strength Index (RSI) 55.48 54.07
Support Level $46.99 $59.12
Resistance Level $54.52 $67.94
Average True Range (ATR) 0.90 2.25
MACD 0.44 0.26
Stochastic Oscillator 75.59 61.73

Price Performance

Historical Comparison
CBSH
CYTK

About CBSH Commerce Bancshares Inc.

Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. It operates through three segments: Consumer, Commercial, and Wealth. The Commercial segment provides corporate lending, payment solutions, leasing, international services, and business banking. The Consumer segment covers retail banking, mortgages, installment lending, and card services. The Wealth segment offers trust and estate planning, brokerage, and investment management services.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: